Health advice for people living in or travelling to countries where the A/H5N1 has been detected
The document contains 12 basic public health questions and answers for people living in or travelling to countries where the A/H5N1 virus has been detected.
Overview of the implementation of COVID-19 vaccination strategies and vaccine deployment plans in the EU/EEA
6 May 2021 - This report provides an updated overview of the progress of national COVID-19 vaccination strategies in EU/EEA countries, including updates on: vaccine uptake overall and by target group; current vaccination phases and priority groups, as well as any adjustments made to priority groups during the rollout; vaccination strategies and policies in place; and the use of vaccination certificates and challenges countries face with the rollout and good practices to mitigate these challenges.
Considerations on the use of rapid antigen detection (including self-) tests for SARS-CoV-2 in occupational settings
6 May 2021 - This document outlines the public health considerations for the use of rapid antigen detection tests (RADTs), including self-test RADTs to detect SARS-CoV-2 in individuals in occupational settings in the European Union/European Economic Area (EU/EEA), and provides information on the use of such tests in an occupational safety and health at work context.
Guidance for representative and targeted genomic SARS-CoV-2 monitoring
3 May 2021 - This document offers practical guidance for EU/EEA Member States on implementing genomic SARS-CoV-2 surveillance. It also includes advice on how to estimate the number of sequenced samples needed to achieve various objectives, including the early detection of novel variants.